Perfil
Amy Franke is Vice President-Clinical Operations at Shattuck Labs, Inc. since 2022.
Former roles include Senior Director-Strategy & Planning at Labcorp Drug Development, Inc., Vice President-Clinical Operations at NervGen Pharma Corp., and Vice President-Clinical Operations at Aravive, Inc. Education includes undergraduate studies at the University of Michigan and graduate studies at the University of Pennsylvania Medical Center.
Cargos activos de Amy Franke
| Empresas | Cargo | Inicio |
|---|---|---|
| SHATTUCK LABS, INC. | Director Técnico/Científico/I+D | 01/10/2022 |
Antiguos cargos conocidos de Amy Franke.
| Empresas | Cargo | Fin |
|---|---|---|
| ARAVIVE, INC. | Director Técnico/Científico/I+D | 01/08/2022 |
| COVANCE INC. | Corporate Officer/Principal | - |
| NERVGEN PHARMA CORP. | Director Técnico/Científico/I+D | - |
Formación de Amy Franke.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 6 |
|---|---|
Labcorp Drug Development, Inc.
Labcorp Drug Development, Inc. Medical/Nursing ServicesHealth Services Provides medical laboratory testing and drug development services | Health Services |
University of Michigan
University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Pennsylvania Medical Center
University of Pennsylvania Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shattuck Labs, Inc.
Shattuck Labs, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops therapeutics for inflammatory and immune-mediated diseases | Health Technology |
NervGen Pharma Corp.
NervGen Pharma Corp. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops neuroreparative therapeutics and pharmaceutical products for neurological disorders | Health Technology |
Aravive, Inc.
Aravive, Inc. BiotechnologyHealth Technology Develops therapies for solid tumors and hematologic malignancies | Health Technology |
- Bolsa de valores
- Insiders
- Amy Franke
















